Together, our data indicate that DOK7 gene therapy suppressed NMJ defects and muscle atrophy in ALS mice with no obvious effects on proximal motor neuron degeneration at 30 days postinfection. This evidence concerns the gene DOK7 and amyotrophic lateral sclerosis.